Jean-Patrick Demonsang
Président chez Demonsang Consulting SAS
Profil
Jean-Patrick Demonsang is currently the Chairman of Demonsang Consulting SAS.
Previously, he served as the Chief Executive Officer of Genode Partners SAS, Chairman of G1j Ile De France, and Chairman of Parexi SAS.
From 2010 to 2013, he was the President & Managing Director of Seventure Partners SA. He also served as a Director at Natixis Venture Sélection SA and an Independent Director at Orphan Synergy Europe-Pharma SA. Demonsang holds an MBA from École des Hautes Études Commerciales de Paris.
Postes actifs de Jean-Patrick Demonsang
| Sociétés | Poste | Début |
|---|---|---|
| Demonsang Consulting SAS | Président | - |
Anciens postes connus de Jean-Patrick Demonsang
| Sociétés | Poste | Fin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Directeur/Membre du Conseil | 22/06/2023 |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Directeur Général | 01/01/2013 |
Natixis Venture Sélection SA
 Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Directeur/Membre du Conseil | - |
| Genode Partners SAS | Directeur Général | - |
| Parexi SAS | Président | - |
Formation de Jean-Patrick Demonsang
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Entreprise privées | 7 |
|---|---|
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
Natixis Venture Sélection SA
Natixis Venture Sélection SA Investment ManagersFinance Natixis Venture Selection SA seeks to invest in French companies operating in a wide range of sectors, it focuses on early and later venture capital stages. | Finance |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Demonsang Consulting SAS | |
| G1j Ile De France | |
| Parexi SAS | |
| Genode Partners SAS |
